论文部分内容阅读
目的2型糖尿病人群采用不同的标准诊断代谢综合征(MS)时,伴有慢性肾脏病(CKD)风险的比较。方法上海中心城区整群抽样了1039例年龄在30岁以上、已诊断为2型糖尿病的患者。检测项目包括身高、体重、腰围、臀围、血压、血糖、血脂、尿白蛋白肌酐比。结果(1)依据中华糖尿病学会(CDS)诊断标准MS者占51.1,MS者中CKD的比例(56.7%)明显高于不伴有MS组(41.5%)(X2=23.121;P<0.01)。(2)采用不同的MS诊断标准,2型糖尿病合并MS人群的CKD的比例不同,由高至低依次为WHO(63.7%)、IDF(58.3%)、CDS(56.7%)、ATPⅢ(53.5%)(X2=14.359;P=0.002)。结论2型糖尿病患者采用WHO标准诊断MS时较其他标准,伴有CKD的风险较大。
Objective To compare the risk of chronic kidney disease (CKD) with different standard diagnostic metabolic syndrome (MS) in people with type 2 diabetes. Methods A total of 1039 patients aged 30 years and older who had been diagnosed with type 2 diabetes were enrolled in the center of Shanghai. Test items include height, weight, waist circumference, hip circumference, blood pressure, blood glucose, blood lipids, urinary albumin creatinine ratio. Results (1) The proportion of CKD in MS was significantly higher than that in non-MS (41.5%) (X2 = 23.121; P <0.01) according to the diagnostic criteria of CDF (51.1%). (2) According to different MS diagnostic criteria, the proportion of CKD in MS patients with type 2 diabetes mellitus was different from WHO to IDF (58.3%), CDS (56.7%) and ATP III (53.5% ) (X2 = 14.359; P = 0.002). Conclusions Patients with type 2 diabetes mellitus have a higher risk of CKD when compared with other criteria when using WHO criteria for the diagnosis of MS.